Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Clinical Association Between Pharmacogenomics and Adverse Drug Reactions
Zhi-Wei Zhou, Xiao-Wu Chen, Kevin Sneed, et al.
Drugs (2015) Vol. 75, Iss. 6, pp. 589-631
Closed Access | Times Cited: 64

Showing 1-25 of 64 citing articles:

Impact of pharmacogenomics on clinical outcomes in major depressive disorder in the GUIDED trial: A large, patient- and rater-blinded, randomized, controlled study
John F. Greden, Sagar V. Parikh, Anthony J. Rothschild, et al.
Journal of Psychiatric Research (2019) Vol. 111, pp. 59-67
Open Access | Times Cited: 268
Potential Adverse Drug Events and Drug–Drug Interactions with Medical and Consumer Cannabidiol (CBD) Use
Joshua D. Brown, Almut G. Winterstein
Journal of Clinical Medicine (2019) Vol. 8, Iss. 7, pp. 989-989
Open Access | Times Cited: 238
PharmVar GeneFocus: CYP2B6
Zeruesenay Desta, Ahmed El‐Boraie, Li Gong, et al.
Clinical Pharmacology & Therapeutics (2021) Vol. 110, Iss. 1, pp. 82-97
Open Access | Times Cited: 214
PharmVar GeneFocus: CYP2D6
Charity Nofziger, Amy Turner, Katrin Sangkuhl, et al.
Clinical Pharmacology & Therapeutics (2019) Vol. 107, Iss. 1, pp. 154-170
Open Access | Times Cited: 186
Constellation: a tool for rapid, automated phenotype assignment of a highly polymorphic pharmacogene, CYP2D6, from whole-genome sequences
Greyson P Twist, Andrea Gaedigk, Neil Miller, et al.
npj Genomic Medicine (2016) Vol. 1, Iss. 1
Open Access | Times Cited: 117
PharmVar GeneFocus: CYP2C19
Mariana Rodrigues Botton, Michelle Whirl‐Carrillo, Andria L. Del Tredici, et al.
Clinical Pharmacology & Therapeutics (2020) Vol. 109, Iss. 2, pp. 352-366
Open Access | Times Cited: 101
The role of pharmacogenomics in adverse drug reactions
Ramón Cacabelos, Natalia Cacabelos, Juan C. Carril
Expert Review of Clinical Pharmacology (2019) Vol. 12, Iss. 5, pp. 407-442
Closed Access | Times Cited: 96
Pharmacogenetics of Anxiety and Depression in Alzheimer’s Disease
Ramón Cacabelos, Juan C. Carril, Lola Corzo, et al.
Pharmacogenomics (2023) Vol. 24, Iss. 1, pp. 27-57
Closed Access | Times Cited: 22
Estimating cost savings of pharmacogenetic testing for depression in real-world clinical settings
Alejandra Maciel, Ali Cullors, Andrew A. Lukowiak, et al.
Neuropsychiatric Disease and Treatment (2018) Vol. Volume 14, pp. 225-230
Open Access | Times Cited: 53
Genome sequencing as a platform for pharmacogenetic genotyping: a pediatric cohort study
Iris Cohn, Tara Paton, Christian R. Marshall, et al.
npj Genomic Medicine (2017) Vol. 2, Iss. 1
Open Access | Times Cited: 51
Pharmacogenomics of Cognitive Dysfunction and Neuropsychiatric Disorders in Dementia
Ramón Cacabelos
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 9, pp. 3059-3059
Open Access | Times Cited: 48
Pharmacogenetic considerations when prescribing cholinesterase inhibitors for the treatment of Alzheimer’s disease
Ramón Cacabelos
Expert Opinion on Drug Metabolism & Toxicology (2020) Vol. 16, Iss. 8, pp. 673-701
Closed Access | Times Cited: 41
The Impact of Cannabidiol on Psychiatric and Medical Conditions
Thersilla Oberbarnscheidt, Norman S. Miller
Journal of Clinical Medicine Research (2020) Vol. 12, Iss. 7, pp. 393-403
Open Access | Times Cited: 40
Genetic diversity of variants involved in drug response among Tunisian and Italian populations toward personalized medicine
Haifa Jmel, Stefania Sarno, Cristina Giuliani, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 5
Effect of pharmacogenomic testing on the clinical treatment of patients with depressive disorder: A randomized clinical trial
Lei Xu, Liyin Li, Qiutang Wang, et al.
Journal of Affective Disorders (2024) Vol. 359, pp. 117-124
Open Access | Times Cited: 4
Prediction of adverse drug reactions based on pharmacogenomics combination features: a preliminary study
Mingxiu He, Yiyang Shi, Fangfang Han, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Review on application and development of pharmacogenomics of adverse drug reactions
Hongyun Bi, Jun Zhu, Yuanxuan Cai, et al.
Journal of Holistic Integrative Pharmacy (2025) Vol. 6, Iss. 1, pp. 105-116
Open Access
A novel machine learning-based approach for the computational functional assessment of pharmacogenomic variants
Maria‐Theodora Pandi, Maria Koromina, Iordanis Tsafaridis, et al.
Human Genomics (2021) Vol. 15, Iss. 1
Open Access | Times Cited: 26
Longitudinal Influence of Prescribed Antidepressants on Fecal and Oral Microbiomes Among Veterans With Major Depressive Disorder
Andrew J. Hoisington, Kelly A. Stearns‐Yoder, Christopher E. Stamper, et al.
Journal of Neuropsychiatry (2024) Vol. 36, Iss. 2, pp. 151-159
Closed Access | Times Cited: 3
Analytical Validation of a Psychiatric Pharmacogenomic Test
Michael Jablonski, Nina King, Yongbao Wang, et al.
Personalized Medicine (2018) Vol. 15, Iss. 3, pp. 189-197
Open Access | Times Cited: 31
Clinical pharmacogenetic analysis in 5,001 individuals with diagnostic Exome Sequencing data
Javier Lanillos, Marta Carcajona, Paolo Maietta, et al.
npj Genomic Medicine (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 15
Farmacogenómica como herramienta fundamental para la medicina personalizada: aplicaciones en la práctica clínica
Luis A. Quiñones, Ángela Roco, Juan Pablo Cayún, et al.
Revista médica de Chile (2017) Vol. 145, Iss. 4, pp. 483-500
Open Access | Times Cited: 27
Personalized Management and Treatment of Alzheimer’s Disease
Ramón Cacabelos, Vinogran Naidoo, Olaia Martínez-Iglesias, et al.
Life (2022) Vol. 12, Iss. 3, pp. 460-460
Open Access | Times Cited: 13
Pharmacogenomics of Alzheimer’s Disease: Novel Strategies for Drug Utilization and Development
Ramón Cacabelos, Vinogran Naidoo, Olaia Martínez-Iglesias, et al.
Methods in molecular biology (2022), pp. 275-387
Closed Access | Times Cited: 13
Role of Pharmacogenetics in Improving the Safety of Psychiatric Care by Predicting the Potential Risks of Mania in CYP2D6 Poor Metabolizers Diagnosed With Bipolar Disorder
Santiago Sánchez-Iglesias, Virginia García-Solaesa, Belén García‐Berrocal, et al.
Medicine (2016) Vol. 95, Iss. 6, pp. e2473-e2473
Open Access | Times Cited: 21
Page 1 - Next Page

Scroll to top